Literature DB >> 23339335

Antidepressant effects of citalopram on treatment of alopecia areata in patients with major depressive disorder.

Hossein Abedini1, Susan Farshi, Arash Mirabzadeh, Saeed Keshavarz.   

Abstract

OBJECTIVE: The authors sought to determine whether antidepressant therapy could enhance the efficacy of dermatological treatment in alopecia areata patients who suffer from major depressive disorder.
METHODS: Sixty patients were enrolled in the study. Thirty patients with alopecia who were diagnosed with major depressive disorder received 20 mg/day citalopram and 5 mg/mL triamcinolone injection every 4 weeks, up to six injections, and 30 patients received only triamcinolone injection each month for 6 months using a simple random method.
RESULTS: The mean diameter of the alopecic patches in the triamcinolone injection only group as against the combined treatment group (psychiatric [citalopram] plus dermatologic treatment) before treatment was 2.7 ± 0.7 (mean ± SD) and 2.5 ± 1.8, respectively, with no statistically significant differences (Mann-Whitney, p = 0.08). After 6 months of therapy, the mean diameter of patches reached 1.6 ± 1 and 0.54 ± 0.97 in the triamcinolone injection only group and the combined treatment groups, respectively (Mann-Whitney, p < 0.0001). DISCUSSION: The results of this study showed that antidepressant treatment might help in improving alopecia areata in patients with major depressive disorder.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23339335     DOI: 10.3109/09546634.2013.768761

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  6 in total

Review 1.  Psychological Aspects of Hair Disorders: Consideration for Dermatologists, Cosmetologists, Aesthetic, and Plastic Surgeons.

Authors:  Cameron R Moattari; Mohammad Jafferany
Journal:  Skin Appendage Disord       Date:  2021-11-23

2.  Effects of anxiety and depression symptoms on oxidative stress in patients with alopecia areata.

Authors:  Gokhan Cakirca; Vildan Manav; Hakim Celik; Gülben Saracoglu; Esra Nur Yetkin
Journal:  Postepy Dermatol Alergol       Date:  2019-03-26       Impact factor: 1.837

Review 3.  [Dermatological diseases and their importance for psychiatry].

Authors:  P Mavrogiorgou; G Juckel
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

4.  Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review.

Authors:  Atrin Toussi; Virginia R Barton; Stephanie T Le; Oma N Agbai; Maija Kiuru
Journal:  J Am Acad Dermatol       Date:  2020-06-17       Impact factor: 15.487

Review 5.  A review of psychiatric disorders comorbidities in patients with alopecia areata.

Authors:  Ahmad Ghanizadeh; Anaheed Ayoobzadehshirazi
Journal:  Int J Trichology       Date:  2014-01

Review 6.  New aspects of the treatment of alopecia areata.

Authors:  Ligia Brzezińska-Wcisło; Beata Bergler-Czop; Dominika Wcisło-Dziadecka; Anna Lis-Święty
Journal:  Postepy Dermatol Alergol       Date:  2014-09-08       Impact factor: 1.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.